首页 > 最新文献

American journal of translational research最新文献

英文 中文
Role of the TLR2/NF-κB signaling pathway and the aggregate index of systemic inflammation as prognostic indicators in papillary thyroid carcinoma. TLR2/NF-κB信号通路及全身性炎症综合指数在甲状腺乳头状癌预后中的作用
IF 1.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-15 eCollection Date: 2025-01-01 DOI: 10.62347/RUQS5111
Yanhong Ren, Guohua Sun, Xiang Huo, Jianlin He, Duting Wang, Kai Zhao

Objective: To investigate the expression of the TLR2/NF-κB signaling pathway and the Aggregate Index of Systemic Inflammation (AISI) in patients with papillary thyroid carcinoma (PTC) and to evaluate their clinical relevance to prognosis.

Methods: In this retrospective study, we analyzed surgically resected tumor tissue samples from 273 patients with PTC (PTC group) and paired adjacent non-tumorous tissues (PT group), as well as 104 nodular goiter tissues (NG group). The AISI values, along with the positive rates and mRNA expression levels of TLR2, MyD88, and NF-κB, were compared among the three groups. Differences in these indicators were compared across PTC patients with different clinicopathologic features. All PTC patients were followed up for three years and categorized into a survival group (n = 70) and a death group (n = 203) based on prognosis, and between-group comparisons were performed. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the prognostic performance of each indicator. Kaplan-Meier survival curves were generated to compare overall survival between high- and low-expression subgroups stratified by TLR2, MyD88, NF-κB mRNA and AISI levels. Cox regression analysis was conducted to identify independent prognostic factors in PTC.

Results: Compared to the NG and PT groups, the PTC group showed higher AISI values, and protein positivity and mRNA expression of TLR2, MyD88, and NF-κB (all P<0.05). In the PTC group, the expression levels of these biomarkers and AISI values differed significantly according to tumor stage, lymph node metastasis, degree of differentiation, and extraglandular extension (P<0.05). Significant differences in differentiation grade, lymph node metastasis, extrathyroidal extension, TLR2, MyD88, NF-κB mRNA, and AISI levels were observed between the survival and death groups (P<0.05). The AUC values for predicting patient prognosis based on TLR2, MyD88, NF-κB mRNA, and AISI individually or in combination were 0.802, 0.795, 0.799, 0.815, and 0.818, respectively. Patients with low expression levels of TLR2, MyD88, NF-κB mRNA, and AISI had significantly longer overall survival compared to those with high expression levels (P<0.05).

Conclusion: Poor differentiation, extrathyroidal extension, and high AISI expression are independent factors for poor PTC prognosis. The TLR2/NF-κB signaling pathway and AISI are closely associated with tumor progression and have prognostic value.

目的:探讨TLR2/NF-κB信号通路与全身性炎症综合指数(AISI)在甲状腺乳头状癌(PTC)患者中的表达及其与预后的临床相关性。方法:回顾性分析273例PTC患者(PTC组)和配对的邻近非肿瘤组织(PT组),以及104例结节性甲状腺肿(NG组)手术切除的肿瘤组织样本。比较三组患者AISI值、TLR2、MyD88、NF-κB mRNA表达水平及阳性率。比较具有不同临床病理特征的PTC患者在这些指标上的差异。所有PTC患者随访3年,根据预后分为生存组(n = 70)和死亡组(n = 203),并进行组间比较。采用受试者工作特征(ROC)曲线分析评价各指标的预后表现。生成Kaplan-Meier生存曲线,比较TLR2、MyD88、NF-κ b mRNA和AISI水平分层的高表达亚组和低表达亚组的总生存率。采用Cox回归分析确定PTC的独立预后因素。结果:与NG组和PT组比较,PTC组AISI值较高,TLR2、MyD88、NF-κB蛋白阳性及mRNA表达均为PTC。结论:分化差、甲状腺外展、AISI高表达是PTC预后差的独立因素。TLR2/NF-κB信号通路和AISI与肿瘤进展密切相关,具有预后价值。
{"title":"Role of the TLR2/NF-κB signaling pathway and the aggregate index of systemic inflammation as prognostic indicators in papillary thyroid carcinoma.","authors":"Yanhong Ren, Guohua Sun, Xiang Huo, Jianlin He, Duting Wang, Kai Zhao","doi":"10.62347/RUQS5111","DOIUrl":"https://doi.org/10.62347/RUQS5111","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the expression of the TLR2/NF-κB signaling pathway and the Aggregate Index of Systemic Inflammation (AISI) in patients with papillary thyroid carcinoma (PTC) and to evaluate their clinical relevance to prognosis.</p><p><strong>Methods: </strong>In this retrospective study, we analyzed surgically resected tumor tissue samples from 273 patients with PTC (PTC group) and paired adjacent non-tumorous tissues (PT group), as well as 104 nodular goiter tissues (NG group). The AISI values, along with the positive rates and mRNA expression levels of TLR2, MyD88, and NF-κB, were compared among the three groups. Differences in these indicators were compared across PTC patients with different clinicopathologic features. All PTC patients were followed up for three years and categorized into a survival group (n = 70) and a death group (n = 203) based on prognosis, and between-group comparisons were performed. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the prognostic performance of each indicator. Kaplan-Meier survival curves were generated to compare overall survival between high- and low-expression subgroups stratified by TLR2, MyD88, NF-κB mRNA and AISI levels. Cox regression analysis was conducted to identify independent prognostic factors in PTC.</p><p><strong>Results: </strong>Compared to the NG and PT groups, the PTC group showed higher AISI values, and protein positivity and mRNA expression of TLR2, MyD88, and NF-κB (all P<0.05). In the PTC group, the expression levels of these biomarkers and AISI values differed significantly according to tumor stage, lymph node metastasis, degree of differentiation, and extraglandular extension (P<0.05). Significant differences in differentiation grade, lymph node metastasis, extrathyroidal extension, TLR2, MyD88, NF-κB mRNA, and AISI levels were observed between the survival and death groups (P<0.05). The AUC values for predicting patient prognosis based on TLR2, MyD88, NF-κB mRNA, and AISI individually or in combination were 0.802, 0.795, 0.799, 0.815, and 0.818, respectively. Patients with low expression levels of TLR2, MyD88, NF-κB mRNA, and AISI had significantly longer overall survival compared to those with high expression levels (P<0.05).</p><p><strong>Conclusion: </strong>Poor differentiation, extrathyroidal extension, and high AISI expression are independent factors for poor PTC prognosis. The TLR2/NF-κB signaling pathway and AISI are closely associated with tumor progression and have prognostic value.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 12","pages":"9695-9704"},"PeriodicalIF":1.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12808019/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145997148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of neoadjuvant endocrine therapy on surgical prognosis and survival period in patients with high-risk localized prostate cancer. 新辅助内分泌治疗对高危局限性前列腺癌患者手术预后及生存期的影响。
IF 1.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-15 eCollection Date: 2025-01-01 DOI: 10.62347/FEWG4694
Bo Wang, Jianzhou Liu, Jie Suo, Junjie Fan, Ruru Xue, Wenbo Mao, Na Liu, Hongyan Liu, Lin Luo

Objective: To investigate the impact of Neoadjuvant Hormonal Therapy (NHT) on surgical prognosis and survival in patients with high-risk localized prostate cancer.

Methods: A retrospective analysis was conducted on 371 high-risk prostate cancer patients who were treated at Baoji Central Hospital and Norinco General Hospital from January 2017 to January 2020. The patients were randomly divided into a training set of 286 cases (134 in the non-NHT group and 151 in the NHT group) and a validation set of 86 cases (42 in the non-NHT group and 44 in the NHT group). All patients underwent radical prostatectomy combined with pelvic lymph node dissection (RP+PLND). The baseline characteristics of the training and validation sets were collected. Surgical efficacy indicators (positive surgical margin rate, operative time, blood loss, etc.), 5-year overall survival (OS), metastasis-free survival (MFS), and biochemical recurrence-free survival (BRFS) were compared between the non-NHT and NHT groups in the training set. Independent risk factors for mortality were identified through univariate and multivariate analyses.

Results: There were no significant differences in the baseline characteristics between the non-NHT and NHT groups in both the validation and training sets. In the training set, the NHT group demonstrated significantly better outcomes than the non-NHT group in terms of positive surgical margin rate (14.57% vs. 39.55%, P < 0.001), intraoperative blood loss (428.64±45.31 ml vs. 494.98±62.36 ml, P < 0.001), and operative time (143.00 min vs. 148.00 min, P < 0.001). The 5-year OS, MFS, and BRFS rates in the NHT group were 82.12% (124/151), 66.23% (100/151), and 40.02% (71/151), respectively, which were significantly higher than 55.97% (75/134), 44.03% (59/134), and 27.61% (37/134) in the non-NHT group (P < 0.001 for all). Multivariate analysis identified non-NHT treatment (OR = 7.528, P < 0.001), open surgery (OR = 4.581, P < 0.001), high clinical stage, high postoperative Gleason score, and high preoperative Prostate-Specific Antigen (PSA) as independent risk factors for mortality. Robotic-assisted surgery significantly reduced the incidence of long-term complications such as urethral stricture and bladder neck contracture compared with open surgery (P < 0.05 for all).

Conclusion: Preoperative NHT can improve surgical efficacy and long-term survival in patients with high-risk prostate cancer without increasing perioperative risks. Robotic-assisted surgery reduces long-term complications. NHT and preoperative PSA can serve as strong predictive indicators for the Nomogram model, providing references for individualized treatment. Further exploration of the optimal course of NHT and precision stratification guided by molecular markers is needed in the future.

目的:探讨新辅助激素治疗(NHT)对高危局限性前列腺癌患者手术预后及生存的影响。方法:回顾性分析2017年1月至2020年1月在宝鸡市中心医院和北方工业总医院接受治疗的高危前列腺癌患者371例。患者被随机分为286例训练组(非NHT组134例,NHT组151例)和86例验证组(非NHT组42例,NHT组44例)。所有患者均行根治性前列腺切除术联合盆腔淋巴结清扫术(RP+PLND)。收集训练集和验证集的基线特征。比较训练集中非NHT组与NHT组的手术疗效指标(手术切边阳性率、手术时间、出血量等)、5年总生存期(OS)、无转移生存期(MFS)、生化无复发生存期(BRFS)。通过单因素和多因素分析确定了死亡率的独立危险因素。结果:在验证集和训练集中,非NHT组和NHT组的基线特征没有显著差异。在训练集中,NHT组在手术切界阳性率(14.57% vs. 39.55%, P < 0.001)、术中出血量(428.64±45.31 ml vs. 494.98±62.36 ml, P < 0.001)和手术时间(143.00 min vs. 148.00 min, P < 0.001)方面均明显优于非NHT组。NHT组5年OS、MFS和BRFS分别为82.12%(124/151)、66.23%(100/151)和40.02%(71/151),显著高于非NHT组的55.97%(75/134)、44.03%(59/134)和27.61% (37/134)(P均< 0.001)。多因素分析发现,非nht治疗(OR = 7.528, P < 0.001)、开放手术(OR = 4.581, P < 0.001)、临床分期高、术后Gleason评分高、术前前列腺特异性抗原(PSA)高是死亡率的独立危险因素。与开放手术相比,机器人辅助手术显著降低了尿道狭窄、膀胱颈挛缩等长期并发症的发生率(P < 0.05)。结论:术前NHT可提高高危前列腺癌患者的手术疗效和远期生存率,且不增加围手术期风险。机器人辅助手术减少了长期并发症。NHT和术前PSA可作为Nomogram模型较强的预测指标,为个体化治疗提供参考。未来需要进一步探索NHT的最佳过程,并在分子标记的指导下进行精确分层。
{"title":"Effects of neoadjuvant endocrine therapy on surgical prognosis and survival period in patients with high-risk localized prostate cancer.","authors":"Bo Wang, Jianzhou Liu, Jie Suo, Junjie Fan, Ruru Xue, Wenbo Mao, Na Liu, Hongyan Liu, Lin Luo","doi":"10.62347/FEWG4694","DOIUrl":"https://doi.org/10.62347/FEWG4694","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the impact of Neoadjuvant Hormonal Therapy (NHT) on surgical prognosis and survival in patients with high-risk localized prostate cancer.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 371 high-risk prostate cancer patients who were treated at Baoji Central Hospital and Norinco General Hospital from January 2017 to January 2020. The patients were randomly divided into a training set of 286 cases (134 in the non-NHT group and 151 in the NHT group) and a validation set of 86 cases (42 in the non-NHT group and 44 in the NHT group). All patients underwent radical prostatectomy combined with pelvic lymph node dissection (RP+PLND). The baseline characteristics of the training and validation sets were collected. Surgical efficacy indicators (positive surgical margin rate, operative time, blood loss, etc.), 5-year overall survival (OS), metastasis-free survival (MFS), and biochemical recurrence-free survival (BRFS) were compared between the non-NHT and NHT groups in the training set. Independent risk factors for mortality were identified through univariate and multivariate analyses.</p><p><strong>Results: </strong>There were no significant differences in the baseline characteristics between the non-NHT and NHT groups in both the validation and training sets. In the training set, the NHT group demonstrated significantly better outcomes than the non-NHT group in terms of positive surgical margin rate (14.57% vs. 39.55%, P < 0.001), intraoperative blood loss (428.64±45.31 ml vs. 494.98±62.36 ml, P < 0.001), and operative time (143.00 min vs. 148.00 min, P < 0.001). The 5-year OS, MFS, and BRFS rates in the NHT group were 82.12% (124/151), 66.23% (100/151), and 40.02% (71/151), respectively, which were significantly higher than 55.97% (75/134), 44.03% (59/134), and 27.61% (37/134) in the non-NHT group (P < 0.001 for all). Multivariate analysis identified non-NHT treatment (OR = 7.528, P < 0.001), open surgery (OR = 4.581, P < 0.001), high clinical stage, high postoperative Gleason score, and high preoperative Prostate-Specific Antigen (PSA) as independent risk factors for mortality. Robotic-assisted surgery significantly reduced the incidence of long-term complications such as urethral stricture and bladder neck contracture compared with open surgery (P < 0.05 for all).</p><p><strong>Conclusion: </strong>Preoperative NHT can improve surgical efficacy and long-term survival in patients with high-risk prostate cancer without increasing perioperative risks. Robotic-assisted surgery reduces long-term complications. NHT and preoperative PSA can serve as strong predictive indicators for the Nomogram model, providing references for individualized treatment. Further exploration of the optimal course of NHT and precision stratification guided by molecular markers is needed in the future.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 12","pages":"9275-9289"},"PeriodicalIF":1.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12808081/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145997153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical efficacy of mechanically activated tissue retractor combined with vacuum sealing drainage for treating deep soft tissue defects: a prospective study. 机械激活组织牵开器联合真空密封引流治疗深部软组织缺损的临床疗效前瞻性研究。
IF 1.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-15 eCollection Date: 2025-01-01 DOI: 10.62347/TORU2999
Baoping Zhao, Siwei Luo, Jialin He, Long Yang, Qiang Zou, Meng Zhang, Benyan Wang, Huihui Yu, Hao Guo, Chuan Ye

Objective: This study aimed to compare the clinical efficacy of mechanically activated tissue retractor (MATR) combined with vacuum sealing drainage (VSD) versus conventional VSD for treating deep soft tissue defects.

Methods: This prospective study included 53 patients with deep soft tissue defects treated between July 2024 and April 2025. The combination group (26 patients) received MATR combined with VSD, while the control group (27 patients) received conventional VSD. Outcome measures included defect healing time, rate of defect healing, mature granulation, graft survival status, pain (Visual Analog Scale, VAS), functional mobility (Activities of Daily Living Scale, ADLS), scarring (Vancouver Scar Scale, VSS), and perioperative complications. Chi-square test, t-test, and ANOVA were used to compare differences.

Results: The combination group demonstrated a significantly shorter defect healing time and lower perioperative complication rate than the control group (all P < 0.05). At 14 days and 21 days after surgery, the combination group demonstrated superior defect healing, mature granulation, and skin survival status compared to the control group (all P < 0.05). Additionally, the combination group had significantly lower VAS scores and higher ADLS scores than the control group (all P < 0.05). At 3 months after defect healing, the combination group again showed significantly lower VAS and VSS scores, and higher ADLS scores than the control group (all P < 0.05).

Conclusion: MATR combined with VSD was more effective in treating deep soft tissue defects compared to conventional VSD.

目的:比较机械激活组织牵开器(MATR)联合真空密封引流术(VSD)与常规VSD治疗深部软组织缺损的临床疗效。方法:本前瞻性研究纳入了2024年7月至2025年4月间治疗的53例深部软组织缺损患者。联合组(26例)采用MATR联合VSD,对照组(27例)采用常规VSD。结果测量包括缺损愈合时间、缺损愈合率、成熟肉芽、移植物存活状态、疼痛(视觉模拟量表,VAS)、功能活动性(日常生活活动量表,ADLS)、疤痕(温哥华疤痕量表,VSS)和围手术期并发症。采用卡方检验、t检验和方差分析比较差异。结果:联合组缺损愈合时间明显短于对照组,围手术期并发症发生率明显低于对照组(均P < 0.05)。术后14天和21天,联合组缺损愈合、肉芽成熟、皮肤存活状况均优于对照组(均P < 0.05)。联合治疗组VAS评分显著低于对照组,ADLS评分显著高于对照组(均P < 0.05)。缺损愈合后3个月,联合组VAS、VSS评分明显低于对照组,ADLS评分明显高于对照组(均P < 0.05)。结论:MATR联合VSD治疗深部软组织缺损较常规VSD更有效。
{"title":"Clinical efficacy of mechanically activated tissue retractor combined with vacuum sealing drainage for treating deep soft tissue defects: a prospective study.","authors":"Baoping Zhao, Siwei Luo, Jialin He, Long Yang, Qiang Zou, Meng Zhang, Benyan Wang, Huihui Yu, Hao Guo, Chuan Ye","doi":"10.62347/TORU2999","DOIUrl":"https://doi.org/10.62347/TORU2999","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to compare the clinical efficacy of mechanically activated tissue retractor (MATR) combined with vacuum sealing drainage (VSD) versus conventional VSD for treating deep soft tissue defects.</p><p><strong>Methods: </strong>This prospective study included 53 patients with deep soft tissue defects treated between July 2024 and April 2025. The combination group (26 patients) received MATR combined with VSD, while the control group (27 patients) received conventional VSD. Outcome measures included defect healing time, rate of defect healing, mature granulation, graft survival status, pain (Visual Analog Scale, VAS), functional mobility (Activities of Daily Living Scale, ADLS), scarring (Vancouver Scar Scale, VSS), and perioperative complications. Chi-square test, t-test, and ANOVA were used to compare differences.</p><p><strong>Results: </strong>The combination group demonstrated a significantly shorter defect healing time and lower perioperative complication rate than the control group (all <i>P</i> < 0.05). At 14 days and 21 days after surgery, the combination group demonstrated superior defect healing, mature granulation, and skin survival status compared to the control group (all <i>P</i> < 0.05). Additionally, the combination group had significantly lower VAS scores and higher ADLS scores than the control group (all <i>P</i> < 0.05). At 3 months after defect healing, the combination group again showed significantly lower VAS and VSS scores, and higher ADLS scores than the control group (all <i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>MATR combined with VSD was more effective in treating deep soft tissue defects compared to conventional VSD.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 12","pages":"9894-9904"},"PeriodicalIF":1.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12808032/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145997273","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expression and clinical significance of IL-17 and its receptor in bacterial pneumonia before and after treatment. IL-17及其受体在细菌性肺炎治疗前后的表达及临床意义
IF 1.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-15 eCollection Date: 2025-01-01 DOI: 10.62347/AHPX9239
Xuehui Zhang, Dongdong Zhou, Jinguo Chu

Objectives: To investigate the expression of serum Interleukin-17 (IL-17) and its receptor IL-17R in patients with bacterial pneumonia and their diagnostic value for severe bacterial pneumonia.

Methods: In this retrospective analysis, 172 patients diagnosed with bacterial pneumonia were included and categorized into the severe (n = 61) and non-severe (n = 111) groups. Serum concentrations of IL-17, IL-17R, procalcitonin (PCT), and high-sensitivity C-reactive protein (hs-CRP) were measured using ELISA upon admission and after antibiotic treatment. ROC curves were drawn to assess the diagnostic performance of influencing factors, correlation analyses were performed to explore relationships among biomarkers, and logistic regression to identify independent risk factors.

Results: Before treatment, patients with severe bacterial pneumonia demonstrated significantly higher levels of IL-17, IL-17R, PCT, and hs-CRP compared to non-severe patients (all P < 0.001). All biomarkers decreased significantly after treatment in severe group (all P < 0.05). IL-17 and IL-17R showed good accuracy in identifying severe disease (AUC = 0.808 and 0.777, respectively) and were positively correlated with PCT and hs-CRP (all P < 0.05). Multivariate analysis identified IL-17, IL-17R, PCT, and hs-CRP as independent risk factors for severe bacterial pneumonia.

Conclusions: IL-17 and IL-17R are elevated in bacterial pneumonia, demonstrating close association with disease severity and conventional markers. Their decline after treatment indicates therapeutic effectiveness. These cytokines show diagnostic potential and could help monitor disease progression and treatment response. Future research should confirm these findings in larger cohorts and investigate their interactions with other inflammatory pathways.

目的:探讨细菌性肺炎患者血清白细胞介素-17 (IL-17)及其受体IL-17R的表达及其对重症细菌性肺炎的诊断价值。方法:回顾性分析172例确诊为细菌性肺炎的患者,分为重症组(n = 61)和非重症组(n = 111)。采用ELISA法测定入院时和抗生素治疗后血清IL-17、IL-17R、降钙素原(PCT)、高敏c反应蛋白(hs-CRP)浓度。绘制ROC曲线评价影响因素的诊断效能,进行相关分析探讨生物标志物之间的关系,进行logistic回归分析确定独立危险因素。结果:治疗前,重症细菌性肺炎患者IL-17、IL-17R、PCT和hs-CRP水平明显高于非重症患者(均P < 0.001)。重症组治疗后各项指标均显著降低(均P < 0.05)。IL-17、IL-17R对危重疾病的鉴别准确率较高(AUC分别为0.808、0.777),且与PCT、hs-CRP呈正相关(P均< 0.05)。多因素分析发现IL-17、IL-17R、PCT和hs-CRP是严重细菌性肺炎的独立危险因素。结论:IL-17和IL-17R在细菌性肺炎中升高,与疾病严重程度和常规标志物密切相关。治疗后其下降表明治疗有效。这些细胞因子具有诊断潜力,可以帮助监测疾病进展和治疗反应。未来的研究应该在更大的队列中证实这些发现,并调查它们与其他炎症途径的相互作用。
{"title":"Expression and clinical significance of IL-17 and its receptor in bacterial pneumonia before and after treatment.","authors":"Xuehui Zhang, Dongdong Zhou, Jinguo Chu","doi":"10.62347/AHPX9239","DOIUrl":"https://doi.org/10.62347/AHPX9239","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the expression of serum Interleukin-17 (IL-17) and its receptor IL-17R in patients with bacterial pneumonia and their diagnostic value for severe bacterial pneumonia.</p><p><strong>Methods: </strong>In this retrospective analysis, 172 patients diagnosed with bacterial pneumonia were included and categorized into the severe (n = 61) and non-severe (n = 111) groups. Serum concentrations of IL-17, IL-17R, procalcitonin (PCT), and high-sensitivity C-reactive protein (hs-CRP) were measured using ELISA upon admission and after antibiotic treatment. ROC curves were drawn to assess the diagnostic performance of influencing factors, correlation analyses were performed to explore relationships among biomarkers, and logistic regression to identify independent risk factors.</p><p><strong>Results: </strong>Before treatment, patients with severe bacterial pneumonia demonstrated significantly higher levels of IL-17, IL-17R, PCT, and hs-CRP compared to non-severe patients (all P < 0.001). All biomarkers decreased significantly after treatment in severe group (all P < 0.05). IL-17 and IL-17R showed good accuracy in identifying severe disease (AUC = 0.808 and 0.777, respectively) and were positively correlated with PCT and hs-CRP (all P < 0.05). Multivariate analysis identified IL-17, IL-17R, PCT, and hs-CRP as independent risk factors for severe bacterial pneumonia.</p><p><strong>Conclusions: </strong>IL-17 and IL-17R are elevated in bacterial pneumonia, demonstrating close association with disease severity and conventional markers. Their decline after treatment indicates therapeutic effectiveness. These cytokines show diagnostic potential and could help monitor disease progression and treatment response. Future research should confirm these findings in larger cohorts and investigate their interactions with other inflammatory pathways.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 12","pages":"9715-9726"},"PeriodicalIF":1.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12808073/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145997276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nanopore sequencing enables rapid diagnosis and drug resistance profiling in refractory Mycoplasma pneumoniae pneumonia: a case report. 纳米孔测序使难治性肺炎支原体肺炎的快速诊断和耐药性分析:一个病例报告。
IF 1.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-15 eCollection Date: 2025-01-01 DOI: 10.62347/FYWL8005
Yuwei Liu, Lin Xu, Yufei Chang, Xiaoyou Chen

Objective: To evaluate the clinical value of nanopore sequencing technology (NST) for the early diagnosis and resistance guidance of Mycoplasma pneumoniae (MP) infection in children.

Methods: We analyzed four pediatric patients with MP pneumonia. Sputum specimens were subjected to NST, and results were compared with serological MP-IgM testing, nucleic acid detection, and chest CT.

Results: In all four cases, MP-IgM yielded false-negative or weakly positive results within the first 5 days. In contrast, NST provided a definitive diagnosis within 24 hours of admission, detecting MP with sequence reads ranging from 14 to 3024 and simultaneously identifying the macrolide-resistant A2063G mutation in the 23S rRNA gene. This led to a confirmed diagnosis 3-7 days earlier than serological methods. Blood cultures were negative in all cases.

Conclusion: NST overcomes the limitations and delay of traditional methods, enabling rapid and accurate diagnosis of MP infection and concurrent detection of resistance mutations. Its integration into clinical practice may significantly improve the management of pediatric MP pneumonia.

目的:评价纳米孔测序技术(NST)对儿童肺炎支原体(MP)感染的早期诊断和耐药性指导的临床价值。方法:对4例小儿MP肺炎患者进行分析。对痰标本进行NST检测,并与血清MP-IgM检测、核酸检测及胸部CT结果进行比较。结果:在所有四例中,MP-IgM在前5天内产生假阴性或弱阳性结果。相比之下,NST在入院24小时内提供了明确的诊断,检测到序列读数从14到3024不等的MP,同时鉴定出23S rRNA基因的大环内酯耐药A2063G突变。这导致确诊时间比血清学方法早3-7天。所有病例血培养均为阴性。结论:NST克服了传统方法的局限性和延迟性,能够快速准确地诊断MP感染并同时检测耐药突变。将其纳入临床实践可显著改善小儿MP肺炎的管理。
{"title":"Nanopore sequencing enables rapid diagnosis and drug resistance profiling in refractory <i>Mycoplasma pneumoniae</i> pneumonia: a case report.","authors":"Yuwei Liu, Lin Xu, Yufei Chang, Xiaoyou Chen","doi":"10.62347/FYWL8005","DOIUrl":"https://doi.org/10.62347/FYWL8005","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the clinical value of nanopore sequencing technology (NST) for the early diagnosis and resistance guidance of <i>Mycoplasma pneumoniae</i> (MP) infection in children.</p><p><strong>Methods: </strong>We analyzed four pediatric patients with MP pneumonia. Sputum specimens were subjected to NST, and results were compared with serological MP-IgM testing, nucleic acid detection, and chest CT.</p><p><strong>Results: </strong>In all four cases, MP-IgM yielded false-negative or weakly positive results within the first 5 days. In contrast, NST provided a definitive diagnosis within 24 hours of admission, detecting MP with sequence reads ranging from 14 to 3024 and simultaneously identifying the macrolide-resistant A2063G mutation in the 23S rRNA gene. This led to a confirmed diagnosis 3-7 days earlier than serological methods. Blood cultures were negative in all cases.</p><p><strong>Conclusion: </strong>NST overcomes the limitations and delay of traditional methods, enabling rapid and accurate diagnosis of MP infection and concurrent detection of resistance mutations. Its integration into clinical practice may significantly improve the management of pediatric MP pneumonia.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 12","pages":"9460-9465"},"PeriodicalIF":1.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12808016/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145996985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impacts of sufentanil/remifentanil plus sevoflurane versus propofol in adults undergoing laparoscopic herniorrhaphy. 舒芬太尼/瑞芬太尼加七氟醚对成人腹腔镜疝修补术的影响。
IF 1.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-15 eCollection Date: 2025-01-01 DOI: 10.62347/XUCP4161
Fabin Huang, Yu Liu, Shaoling Qiu

Objective: To retrospectively explore how sevoflurane + sufentanil/remifentanil versus propofol + sufentanil/remifentanil impacts clinical outcomes in laparoscopic herniorrhaphy-treated adults.

Methods: We enrolled 102 adult patients grouped into propofol (n=50) and sevoflurane (n=52) groups. Inter-group comparisons were made regarding operative duration, time to induction, extubation, emergence, and consciousness recovery, agitation incidence, first ambulation time, length of stay, and gastrointestinal recovery. Adverse events, hemodynamic parameters, as well as preoperative and postoperative stress markers, inflammatory cytokines, and pain mediators, were also discussed.

Results: The sevoflurane group had statistically shorter times to extubation, consciousness recovery, first ambulation, and gastrointestinal restoration, along with lower agitation and overall adverse event rates. Shorter anesthesia emergence time and more stable hemodynamic parameters were also found in patients receiving sevoflurane compared to the propofol cohort. Better performance in postoperative stress response, inflammatory markers, and pain mediators (except for a milder decrease in β-endorphin [β-EP]) was also determined in sevoflurane-treated patients. No notable intergroup differences were identified in the durations of surgery, induction, and hospitalization.

Conclusion: Compared to the propofol combination, the sevoflurane-sufentanil/remifentanil regimen applied to adult laparoscopic hernia repair patients contributed to superior clinical outcomes.

目的:回顾性探讨七氟醚+舒芬太尼/瑞芬太尼与异丙酚+舒芬太尼/瑞芬太尼对成人腹腔镜疝修补术临床疗效的影响。方法:将102例成人患者分为异丙酚组(n=50)和七氟醚组(n=52)。组间比较手术时间、诱导时间、拔管时间、出现时间、意识恢复时间、躁动发生率、首次下床时间、住院时间和胃肠道恢复情况。不良事件,血流动力学参数,以及术前和术后应激标志物,炎症细胞因子和疼痛介质,也进行了讨论。结果:七氟醚组拔管时间、意识恢复时间、首次活动时间和胃肠道恢复时间较短,躁动和总体不良事件发生率较低。与异丙酚组相比,七氟醚组麻醉出现时间更短,血流动力学参数更稳定。七氟醚治疗的患者在术后应激反应、炎症标志物和疼痛介质方面也有更好的表现(除了β-内啡肽[β-EP]的轻微下降)。手术时间、诱导时间和住院时间组间无显著差异。结论:与异丙酚联合用药相比,七氟醚-舒芬太尼/瑞芬太尼方案用于成人腹腔镜疝修补患者的临床效果更好。
{"title":"Impacts of sufentanil/remifentanil plus sevoflurane versus propofol in adults undergoing laparoscopic herniorrhaphy.","authors":"Fabin Huang, Yu Liu, Shaoling Qiu","doi":"10.62347/XUCP4161","DOIUrl":"https://doi.org/10.62347/XUCP4161","url":null,"abstract":"<p><strong>Objective: </strong>To retrospectively explore how sevoflurane + sufentanil/remifentanil versus propofol + sufentanil/remifentanil impacts clinical outcomes in laparoscopic herniorrhaphy-treated adults.</p><p><strong>Methods: </strong>We enrolled 102 adult patients grouped into propofol (n=50) and sevoflurane (n=52) groups. Inter-group comparisons were made regarding operative duration, time to induction, extubation, emergence, and consciousness recovery, agitation incidence, first ambulation time, length of stay, and gastrointestinal recovery. Adverse events, hemodynamic parameters, as well as preoperative and postoperative stress markers, inflammatory cytokines, and pain mediators, were also discussed.</p><p><strong>Results: </strong>The sevoflurane group had statistically shorter times to extubation, consciousness recovery, first ambulation, and gastrointestinal restoration, along with lower agitation and overall adverse event rates. Shorter anesthesia emergence time and more stable hemodynamic parameters were also found in patients receiving sevoflurane compared to the propofol cohort. Better performance in postoperative stress response, inflammatory markers, and pain mediators (except for a milder decrease in β-endorphin [β-EP]) was also determined in sevoflurane-treated patients. No notable intergroup differences were identified in the durations of surgery, induction, and hospitalization.</p><p><strong>Conclusion: </strong>Compared to the propofol combination, the sevoflurane-sufentanil/remifentanil regimen applied to adult laparoscopic hernia repair patients contributed to superior clinical outcomes.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 12","pages":"10008-10016"},"PeriodicalIF":1.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12808079/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145997032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Percutaneous kyphoplasty improves surgical outcomes and quality of life in elderly patients with osteoporotic vertebral compression fractures. 经皮椎体后凸成形术改善老年骨质疏松性椎体压缩性骨折患者的手术效果和生活质量。
IF 1.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-15 eCollection Date: 2025-01-01 DOI: 10.62347/GYHV3809
Rui Zhang, Ao Yan, Runze Zhao, Renxin Xu, Hanjun Zhang, Mi Li, Tao Zhang

Objective: To evaluate the effects of percutaneous kyphoplasty (PKP) on surgical outcomes and postoperative well-being in elderly patients with osteoporotic vertebral compression fractures (OVCFs).

Methods: A total of 118 geriatric patients with OVCF treated at the Fourth Affiliated Hospital of Harbin Medical University between March 2022 and March 2025 were retrospectively analyzed. Among them, 54 underwent percutaneous vertebroplasty (PVP group), and 64 received PKP (PKP group). Data collected included surgical outcomes (bone cement injection volume, operative duration) and vertebral morphological parameters (kyphotic Cobb angle, mid/anterior vertebral height). Bone mineral density (BMD) and bone metabolism markers, including osteocalcin (BGP), bone-specific alkaline phosphatase (BALP), were assessed. Functional outcomes (Visual Analog Scale [VAS], Oswestry Disability Index [ODI], and Japanese Orthopaedic Association [JOA] Scale) were evaluated. Additionally, complications such as cement leakage, infection, and pressure ulcers were monitored. Quality of life was assessed using the Short Form-36 Health Survey (SF-36). Variables associated with pain relief were identified through univariate screening followed by multivariate analysis.

Results: Compared with PVP, PKP involved more bone cement use and longer procedural duration. However, PKP achieved more pronounced reductions in post-treatment Cobb angle, VAS, and ODI scores than PVP, along with more significant increases in mid/anterior vertebral height, BMD, BGP, BALP, JOA, and SF-36 scores. The complication rate was similar between groups.

Conclusion: In geriatric OVCF cases, PKP enhances vertebral morphology, BMD, bone metabolism, functional recovery, and patient well-being, while maintaining a safety profile comparable to PVP, despite requiring greater cement volumes and extended surgery time.

目的:探讨经皮椎体后凸成形术(PKP)对老年骨质疏松性椎体压缩性骨折(ovcf)患者手术效果和术后幸福感的影响。方法:回顾性分析2022年3月至2025年3月在哈尔滨医科大学第四附属医院治疗的118例老年OVCF患者。其中经皮椎体成形术54例(PVP组),PKP组64例(PKP组)。收集的数据包括手术结果(骨水泥注射量、手术时间)和椎体形态学参数(后凸Cobb角、椎体中前高度)。评估骨矿物质密度(BMD)和骨代谢指标,包括骨钙素(BGP)、骨特异性碱性磷酸酶(BALP)。功能结果(视觉模拟量表[VAS]、Oswestry残疾指数[ODI]和日本骨科协会[JOA]量表)进行评估。此外,还监测了水泥渗漏、感染和压疮等并发症。使用SF-36健康调查问卷(SF-36)评估生活质量。通过单因素筛选和多因素分析确定与疼痛缓解相关的变量。结果:与PVP相比,PKP使用骨水泥较多,手术时间较长。然而,与PVP相比,PKP治疗后Cobb角、VAS和ODI评分的降低更为明显,同时椎体中前高度、BMD、BGP、BALP、JOA和SF-36评分的增加更为显著。两组间并发症发生率相似。结论:在老年OVCF病例中,PKP可以增强椎体形态、骨密度、骨代谢、功能恢复和患者健康,同时保持与PVP相当的安全性,尽管需要更大的水泥体积和延长的手术时间。
{"title":"Percutaneous kyphoplasty improves surgical outcomes and quality of life in elderly patients with osteoporotic vertebral compression fractures.","authors":"Rui Zhang, Ao Yan, Runze Zhao, Renxin Xu, Hanjun Zhang, Mi Li, Tao Zhang","doi":"10.62347/GYHV3809","DOIUrl":"https://doi.org/10.62347/GYHV3809","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the effects of percutaneous kyphoplasty (PKP) on surgical outcomes and postoperative well-being in elderly patients with osteoporotic vertebral compression fractures (OVCFs).</p><p><strong>Methods: </strong>A total of 118 geriatric patients with OVCF treated at the Fourth Affiliated Hospital of Harbin Medical University between March 2022 and March 2025 were retrospectively analyzed. Among them, 54 underwent percutaneous vertebroplasty (PVP group), and 64 received PKP (PKP group). Data collected included surgical outcomes (bone cement injection volume, operative duration) and vertebral morphological parameters (kyphotic Cobb angle, mid/anterior vertebral height). Bone mineral density (BMD) and bone metabolism markers, including osteocalcin (BGP), bone-specific alkaline phosphatase (BALP), were assessed. Functional outcomes (Visual Analog Scale [VAS], Oswestry Disability Index [ODI], and Japanese Orthopaedic Association [JOA] Scale) were evaluated. Additionally, complications such as cement leakage, infection, and pressure ulcers were monitored. Quality of life was assessed using the Short Form-36 Health Survey (SF-36). Variables associated with pain relief were identified through univariate screening followed by multivariate analysis.</p><p><strong>Results: </strong>Compared with PVP, PKP involved more bone cement use and longer procedural duration. However, PKP achieved more pronounced reductions in post-treatment Cobb angle, VAS, and ODI scores than PVP, along with more significant increases in mid/anterior vertebral height, BMD, BGP, BALP, JOA, and SF-36 scores. The complication rate was similar between groups.</p><p><strong>Conclusion: </strong>In geriatric OVCF cases, PKP enhances vertebral morphology, BMD, bone metabolism, functional recovery, and patient well-being, while maintaining a safety profile comparable to PVP, despite requiring greater cement volumes and extended surgery time.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 12","pages":"9739-9748"},"PeriodicalIF":1.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12808029/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145997078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A clinical and CT-based model for differentiating high-grade from low-grade lung adenocarcinoma in patients with idiopathic pulmonary fibrosis. 特发性肺纤维化患者高级别肺腺癌与低级别肺腺癌鉴别的临床和ct模型
IF 1.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-15 eCollection Date: 2025-01-01 DOI: 10.62347/MVTV2288
Qianli Ma, Weina Li, Lin Chen, Xunhui Zhuang

Objectives: To establish a clinical and CT-based diagnostic model to predict high-grade lung adenocarcinoma (LAC) in patients with idiopathic pulmonary fibrosis (IPF).

Methods: A total of 289 LAC-IPF patients were enrolled retrospectively and were divided into training (n=171) and test sets (n=118). In each set, the patients were divided into a low-grade LAC group and high-grade LAC group according to pathologic findings. Clinical and high-resolution CT (HRCT) features were analyzed by binary logistic regression analysis to select independent predictors for high-grade LAC by building three models: the clinical model, the radiologic model, and the combined model integrating the independent clinical and radiologic factors. The discriminative performance of the three models was assessed using the receiver operating characteristic (ROC). The model with the best diagnostic performance was verified in the test set.

Results: There was no significant difference between the training and test sets regarding clinical and radiologic factors (P>0.05). The usual interstitial pneumonia (UIP) pattern of IPF, solid morphology of the tumor, cytokeratin 19 fragments (CYFRA21-1, the cutoff value: 2.85 ng/mL) and smoking history were identified as independent predictors for high-grade LAC. The combined model showed the best discriminative performance (AUC: 0.955 in the training set and 0.853 in the test set), with sensitivity, specificity, and accuracy of 94.0%, 87.1%, and 91.2%, respectively.

Conclusions: A clinical and CT-based model can be used as an effective tool to predict high-grade LAC in IPF patients.

目的:建立一种基于临床和ct的诊断模型来预测特发性肺纤维化(IPF)患者的高级别肺腺癌(LAC)。方法:回顾性纳入289例LAC-IPF患者,分为训练组(n=171)和试验组(n=118)。每组患者根据病理表现分为低级别LAC组和高级别LAC组。采用二元logistic回归分析临床和高分辨率CT (HRCT)特征,通过建立临床模型、放射学模型和临床与放射学独立因素的联合模型,选择高级别LAC的独立预测因子。采用受试者工作特征(ROC)对三种模型的判别性能进行评估。在测试集中验证了诊断性能最好的模型。结果:训练组与测试组在临床和放射学因素方面差异无统计学意义(P < 0.05)。IPF的常见间质性肺炎(UIP)模式、肿瘤的实体形态、细胞角蛋白19片段(CYFRA21-1,临界值:2.85 ng/mL)和吸烟史被确定为高度LAC的独立预测因素。联合模型的判别性能最佳(训练集AUC为0.955,测试集AUC为0.853),灵敏度为94.0%,特异度为87.1%,准确率为91.2%。结论:临床和基于ct的模型可作为预测IPF患者高级别LAC的有效工具。
{"title":"A clinical and CT-based model for differentiating high-grade from low-grade lung adenocarcinoma in patients with idiopathic pulmonary fibrosis.","authors":"Qianli Ma, Weina Li, Lin Chen, Xunhui Zhuang","doi":"10.62347/MVTV2288","DOIUrl":"https://doi.org/10.62347/MVTV2288","url":null,"abstract":"<p><strong>Objectives: </strong>To establish a clinical and CT-based diagnostic model to predict high-grade lung adenocarcinoma (LAC) in patients with idiopathic pulmonary fibrosis (IPF).</p><p><strong>Methods: </strong>A total of 289 LAC-IPF patients were enrolled retrospectively and were divided into training (n=171) and test sets (n=118). In each set, the patients were divided into a low-grade LAC group and high-grade LAC group according to pathologic findings. Clinical and high-resolution CT (HRCT) features were analyzed by binary logistic regression analysis to select independent predictors for high-grade LAC by building three models: the clinical model, the radiologic model, and the combined model integrating the independent clinical and radiologic factors. The discriminative performance of the three models was assessed using the receiver operating characteristic (ROC). The model with the best diagnostic performance was verified in the test set.</p><p><strong>Results: </strong>There was no significant difference between the training and test sets regarding clinical and radiologic factors (<i>P</i>>0.05). The usual interstitial pneumonia (UIP) pattern of IPF, solid morphology of the tumor, cytokeratin 19 fragments (CYFRA21-1, the cutoff value: 2.85 ng/mL) and smoking history were identified as independent predictors for high-grade LAC. The combined model showed the best discriminative performance (AUC: 0.955 in the training set and 0.853 in the test set), with sensitivity, specificity, and accuracy of 94.0%, 87.1%, and 91.2%, respectively.</p><p><strong>Conclusions: </strong>A clinical and CT-based model can be used as an effective tool to predict high-grade LAC in IPF patients.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 12","pages":"9412-9421"},"PeriodicalIF":1.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12808069/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145997088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between delayed methotrexate metabolism, coagulation function, and adverse reactions in patients with acute lymphoblastic leukemia receiving high-dose methotrexate treatment. 接受大剂量甲氨蝶呤治疗的急性淋巴细胞白血病患者延迟甲氨蝶呤代谢、凝血功能和不良反应之间的关系
IF 1.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-15 eCollection Date: 2025-01-01 DOI: 10.62347/GDXH3501
Jing Xu, Guoqiang Huang, Xiaopeng Liu, Xiaoying Zhao, Xin Chen

Objective: This study aimed to identify the risk factors associated with delayed drug metabolism during high-dose methotrexate (HD-MTX) therapy and to analyze the relationship between delayed metabolism and post-treatment toxic adverse effects.

Methods: A retrospective analysis was performed on 189 patients with acute lymphoblastic leukemia who received HD-MTX therapy at Xi'an Gaoxin Hospital between February 2018 and May 2023. Serum MTX concentrations were measured at 24, 48, and 72 hours after each HD-MTX administration (cycle), with a 48-hour concentration ≥ 1 μmol/L defining delayed metabolism on a per-cycle basis. Clinical characteristics and laboratory parameters were collected, and univariate and multivariate logistic regression analyses were conducted using SPSS version 27.00 and R version 4.3.3 to determine the risk factors for delayed metabolism. Receiver operating characteristic (ROC) curve analysis was used to evaluate the predictive performance of each significant factor.

Results: Significant differences were observed between the delayed cycles (n = 105) and the non-delayed cycles (n = 450) across several clinical and laboratory variables, including age, body mass index (BMI), MTX dosage, activated partial thromboplastin time (APTT), and D-dimer (DD). Logistic regression analysis identified age, BMI, body surface area, MTX dosage, APTT, fibrinogen, DD, albumin, creatinine clearance rate, and phosphorus levels as independent risk factors for delayed metabolism. ROC curve analysis demonstrated that DD exhibited high predictive accuracy for delayed metabolism (area under the curve = 0.833). Moreover, delayed metabolism was significantly associated with a higher incidence of treatment-related toxicities, including mucosal injury, myelosuppression, renal impairment, and gastrointestinal reactions.

Conclusion: Delayed MTX metabolism is influenced by multiple clinical and biochemical factors, with DD emerging as a key predictor. Patients experiencing delayed metabolism are at greater risk for severe treatment-related toxicities. Clinicians should closely monitor these high-risk patients and consider timely preventive or corrective interventions to mitigate adverse outcomes.

目的:本研究旨在探讨高剂量甲氨蝶呤(HD-MTX)治疗中药物代谢延迟的相关危险因素,分析代谢延迟与治疗后毒副反应的关系。方法:对2018年2月至2023年5月在西安高新医院接受HD-MTX治疗的189例急性淋巴细胞白血病患者进行回顾性分析。在每个HD-MTX给药(周期)后24、48和72小时测定血清MTX浓度,48小时浓度≥1 μmol/L定义为每个周期的延迟代谢。收集临床特征和实验室参数,采用SPSS 27.00和R 4.3.3进行单因素和多因素logistic回归分析,确定延迟代谢的危险因素。采用受试者工作特征(ROC)曲线分析评价各显著因素的预测效果。结果:延迟周期(n = 105)和非延迟周期(n = 450)在几个临床和实验室变量中观察到显着差异,包括年龄,体重指数(BMI), MTX剂量,活化部分凝血活素时间(APTT)和d -二聚体(DD)。Logistic回归分析发现,年龄、BMI、体表面积、MTX剂量、APTT、纤维蛋白原、DD、白蛋白、肌酐清除率和磷水平是延迟代谢的独立危险因素。ROC曲线分析表明,DD对延迟代谢具有较高的预测准确度(曲线下面积= 0.833)。此外,代谢延迟与治疗相关毒性的高发生率显著相关,包括粘膜损伤、骨髓抑制、肾损害和胃肠道反应。结论:MTX代谢延迟受多种临床和生化因素的影响,DD是一个重要的预测因素。经历代谢延迟的患者发生严重治疗相关毒性的风险更大。临床医生应密切监测这些高危患者,并考虑及时采取预防或纠正措施,以减轻不良后果。
{"title":"Association between delayed methotrexate metabolism, coagulation function, and adverse reactions in patients with acute lymphoblastic leukemia receiving high-dose methotrexate treatment.","authors":"Jing Xu, Guoqiang Huang, Xiaopeng Liu, Xiaoying Zhao, Xin Chen","doi":"10.62347/GDXH3501","DOIUrl":"https://doi.org/10.62347/GDXH3501","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to identify the risk factors associated with delayed drug metabolism during high-dose methotrexate (HD-MTX) therapy and to analyze the relationship between delayed metabolism and post-treatment toxic adverse effects.</p><p><strong>Methods: </strong>A retrospective analysis was performed on 189 patients with acute lymphoblastic leukemia who received HD-MTX therapy at Xi'an Gaoxin Hospital between February 2018 and May 2023. Serum MTX concentrations were measured at 24, 48, and 72 hours after each HD-MTX administration (cycle), with a 48-hour concentration ≥ 1 μmol/L defining delayed metabolism on a per-cycle basis. Clinical characteristics and laboratory parameters were collected, and univariate and multivariate logistic regression analyses were conducted using SPSS version 27.00 and R version 4.3.3 to determine the risk factors for delayed metabolism. Receiver operating characteristic (ROC) curve analysis was used to evaluate the predictive performance of each significant factor.</p><p><strong>Results: </strong>Significant differences were observed between the delayed cycles (n = 105) and the non-delayed cycles (n = 450) across several clinical and laboratory variables, including age, body mass index (BMI), MTX dosage, activated partial thromboplastin time (APTT), and D-dimer (DD). Logistic regression analysis identified age, BMI, body surface area, MTX dosage, APTT, fibrinogen, DD, albumin, creatinine clearance rate, and phosphorus levels as independent risk factors for delayed metabolism. ROC curve analysis demonstrated that DD exhibited high predictive accuracy for delayed metabolism (area under the curve = 0.833). Moreover, delayed metabolism was significantly associated with a higher incidence of treatment-related toxicities, including mucosal injury, myelosuppression, renal impairment, and gastrointestinal reactions.</p><p><strong>Conclusion: </strong>Delayed MTX metabolism is influenced by multiple clinical and biochemical factors, with DD emerging as a key predictor. Patients experiencing delayed metabolism are at greater risk for severe treatment-related toxicities. Clinicians should closely monitor these high-risk patients and consider timely preventive or corrective interventions to mitigate adverse outcomes.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 12","pages":"9566-9579"},"PeriodicalIF":1.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12808053/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145997096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acupuncture alleviates renal edema through upregulation of renal aquaporin expression. 针刺通过上调肾水通道蛋白表达减轻肾水肿。
IF 1.6 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-15 eCollection Date: 2025-01-01 DOI: 10.62347/MVCU9398
Yi Zhu, Ping Hu, Youhua Xu, Niansong Wang

Objective: This study aimed to investigate the principles of acupoint selection and the prescription characteristics of acupuncture therapy for renal edema.

Methods: Data mining technology was adopted to identify high-frequency acupoints and commonly used prescription combinations. Eight rats were selected as the control group without drug intervention, while the remaining rats were divided into the control group, model group, sham acupuncture group, and acupuncture group. Serum Ig-M and Ig-G expression levels were assessed by western blotting, and renal expression of AQP2 and AQP3 was examined using immunofluorescence.

Results: In prescriptions for renal edema, the five most frequently selected acupoints were Shenshu (BL23), Shuishui (ST28), Guanyuan (CV4), Pishu (BL20), and Zusanli (ST36). The four most frequently involved meridians were the Bladder Meridian of Foot-Taiyang, the Conception Vessel, the Kidney Meridian of Foot-Shaoyin, and the Governor Vessel. Commonly used acupoints included Yinlingquan (SP9), Yongquan (KI1), Guanyuan (CV4), Pishu (BL20), Zusanli (ST36), Shenque (CV8), and Shuifen (CV9). Compared to the blank group, the model group exhibited significantly increased serum IgM and IgG expression, while these levels were reduced in the acupuncture group. In contrast, renal AQP2 and AQP3 expression was significantly decreased in the model group relative to the blank group (P<0.05).

Conclusion: Acupuncture targeting the Bladder Meridian of Foot-Taiyang, the Conception Vessel, the Kidney Meridian of Foot-Shaoyin, and the Governor Vessel can alleviate renal edema by enhancing renal aquaporin expression and attenuating inflammatory response.

目的:探讨针刺治疗肾水肿的取穴原则及方剂特点。方法:采用数据挖掘技术识别高频穴位和常用处方组合。取8只大鼠作为不进行药物干预的对照组,其余大鼠分为对照组、模型组、假针组、针刺组。免疫印迹法检测血清中igg - m和igg - g的表达水平,免疫荧光法检测肾脏中AQP2和AQP3的表达。结果:肾水肿方剂中,最常选用的5个穴位为肾俞(BL23)、水水(ST28)、官园(CV4)、脾俞(BL20)、足三里(ST36)。四条最常涉及的经脉是足太阳膀胱经脉、受孕经脉、足少阴肾经脉和督脉。常用穴位有银灵泉(SP9)、涌泉(KI1)、官园(CV4)、脾俞(BL20)、足三里(ST36)、肾阙(CV8)、水芬(CV9)。与空白组比较,模型组血清IgM、IgG表达明显升高,针刺组血清IgM、IgG表达降低。与空白组相比,模型组大鼠肾脏AQP2、AQP3表达明显降低(p)。结论:针刺足太阳膀胱经、孕经、足少阴肾经、督脉可通过提高肾水通道蛋白表达、减轻炎症反应来减轻肾水肿。
{"title":"Acupuncture alleviates renal edema through upregulation of renal aquaporin expression.","authors":"Yi Zhu, Ping Hu, Youhua Xu, Niansong Wang","doi":"10.62347/MVCU9398","DOIUrl":"https://doi.org/10.62347/MVCU9398","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to investigate the principles of acupoint selection and the prescription characteristics of acupuncture therapy for renal edema.</p><p><strong>Methods: </strong>Data mining technology was adopted to identify high-frequency acupoints and commonly used prescription combinations. Eight rats were selected as the control group without drug intervention, while the remaining rats were divided into the control group, model group, sham acupuncture group, and acupuncture group. Serum Ig-M and Ig-G expression levels were assessed by western blotting, and renal expression of AQP2 and AQP3 was examined using immunofluorescence.</p><p><strong>Results: </strong>In prescriptions for renal edema, the five most frequently selected acupoints were Shenshu (BL23), Shuishui (ST28), Guanyuan (CV4), Pishu (BL20), and Zusanli (ST36). The four most frequently involved meridians were the Bladder Meridian of Foot-Taiyang, the Conception Vessel, the Kidney Meridian of Foot-Shaoyin, and the Governor Vessel. Commonly used acupoints included Yinlingquan (SP9), Yongquan (KI1), Guanyuan (CV4), Pishu (BL20), Zusanli (ST36), Shenque (CV8), and Shuifen (CV9). Compared to the blank group, the model group exhibited significantly increased serum IgM and IgG expression, while these levels were reduced in the acupuncture group. In contrast, renal AQP2 and AQP3 expression was significantly decreased in the model group relative to the blank group (<i>P</i><0.05).</p><p><strong>Conclusion: </strong>Acupuncture targeting the Bladder Meridian of Foot-Taiyang, the Conception Vessel, the Kidney Meridian of Foot-Shaoyin, and the Governor Vessel can alleviate renal edema by enhancing renal aquaporin expression and attenuating inflammatory response.</p>","PeriodicalId":7731,"journal":{"name":"American journal of translational research","volume":"17 12","pages":"9786-9799"},"PeriodicalIF":1.6,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12808061/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145997124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American journal of translational research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1